Patent · US Active

Anti-PD-1/anti-HER2 natural antibody structural heterodimeric bispecific antibody and method of preparing the same

US11319378B2 · kind B2 · utility

1Cited by
11References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 16, 2017
Grant dateMay 3, 2022
Priority date
Expiry dateJul 15, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Provided are an anti-PD-1/anti-HER2 natural antibody structural heterodimeric bispecific antibody and a method of preparing the same. Specifically, provided are a highly stable anti-PD-1/anti-HER2 heterodimeric bispecific antibody having characteristics of a natural IgG and having no mismatched heavy chain and light chain, and a method of preparing the same. The bispecific antibody may bind to both of two kinds of target molecules, and thus may be more effective in treating complex diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.